PErioperative CISGEM + Rilvegostomig in High-Risk Resectable Intra Hepatic CholangioCarcinoma
PErioperative CISGEM + Rilvegostomig in High-Risk Resectable Intra Hepatic CholangioCarcinoma
Not yet recruiting · NCT07128290 · Registry updated 2025-08-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| PErioperative CISGEM + Rilvegostomig in High-Risk Resectable Intra Hepatic CholangioCarcinoma | Cirrhosis, Familial, with Pulmonary Hypertension, Neoplasms by Histologic Type, adenocarcinoma, carcinoma, cholangiocarcinoma, epithelial neoplasm, neoplasm | Not yet recruiting | Phase 2 | 2025-08-17 | NCT07128290 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Federation Francophone de Cancerologie Digestive | 19 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centre Gf Leclerc | Dijon | France | 1 |
| CHU Caen Normandie | Caen | France | 4 |
| Chu de Dijon | Dijon | France | 24 |
| CHU de Poitiers | Poitiers | France | 40 |
| Chu Dupuytren | Limoges | France | 15 |
| CHU Grenoble Alpes | Grenoble | France | 25 |
| Hopital de La Timone Ap-Hm | Marseille | France | 1 |
| Hopital Prive Du Confluent | Nantes | France | 3 |
| Nancy Chru | Nancy | France | 1 |